Antimicrobial agentsa | Asymptomatic carriers (n = 52) | CAP carriers (n = 31) | ||||
---|---|---|---|---|---|---|
CC271, n (%) | Others, n (%) | P valuesb | CC271, n (%) | Others, n (%) | P valuesb | |
ERY | 6 (100) | 46 (100) | – | 15 (100) | 6 (100) | – |
CLI | 6 (100) | 46 (100) | – | 15 (100) | 6 (100) | – |
SXT | 6 (100) | 38 (82.6) | 0.573 | 15 (100) | 6 (100) | 0.043 |
TET | 6 (100) | 34 (73.9) | 0.316 | 15 (100) | 6 (100) | 1.000 |
CXM | 6 (100) | 19 (41.3) | 0.002 | 14 (93.3) | 6 (100) | 0.009 |
CHL | 0 (0.0) | 5 (10.9) | 1.000 | 2 (13.3) | 0 (0.0) | 0.600 |
CEF | 4 (66.7) | 1 (2.2) | 0.000 | 8 (53.3) | 4 (66.7) | 0.015 |
PEN | 6 (100) | 31 (67.4) | 0.165 | 14 (93.3) | 6 (100) | 0.015 |
CRO (Non-meningitis) | 0 (0.0) | 0 (0.0) | – | 0 (0.0) | 0 (0.0) | 0.484 |
MER | 3 (50.0) | 2 (4.4) | 0.043 | 4 (26.7) | 3 (50.0) | 0.008 |
CFP (Non-meningitis) | 4 (66.7) | 0 (0.0) | 0.037 | 6 (40.0) | 4 (66.7) | 0.000 |
MOX | 0 (0.0) | 0 (0.0) | – | 0 (0.0) | 0 (0.0) | – |
LEV | 0 (0.0) | 1 (2.2) | 1.000 | 0 (0.0) | 0 (0.0) | – |
VAN | 0 (0.0) | 0 (0.0) | – | 2 (13.3) | 0 (0.0) | 0.226 |
RIF | 0 (0.0) | 1 (2.2) | 1.000 | 3 (0.2) | 0 (0.0) | 0.101 |
AMPC/CVA (Non-meningitis) | 1 (16.7) | 0 (0.0) | 0.115 | 1 (6.7) | 1 (16.7) | 1.000 |
LIN | 1 (16.7) | 1 (2.2) | 0.219 | 2 (13.3) | 1 (16.7) | 0.226 |